Hims & Hers Health, Inc. (HIMS) Misses Q1 EPS by 41c, Misses on Revenue; Offers FY26 Revenue Guidance

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q1 EPS of ($0.40), $0.41 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $608 million versus the consensus estimate of $616.5 million.

GUIDANCE:

Hims & Hers Health, Inc. sees FY2026 revenue of $2.8-3 billion, versus the consensus of $2.72 billion.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Laser Photonics regains NASDAQ compliance after filing quarterly report
• TechCreate Group faces NYSE American delisting proceedings